United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - arsenic trioxide - solution for infusion - 1mg/1ml

New Zealand - English - Medsafe (Medicines Safety Authority)

phebra nz limited - arsenic trioxide 1 mg/ml - concentrate for infusion - 10 mg/10ml - active: arsenic trioxide 1 mg/ml excipient: hydrochloric acid sodium hydroxide water for injection - for the induction of remission and consolidation in patients with acute promyelocytic leukaemia (apl) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose apl is characterised by the presence of the t(15:17) translocation or pml/rar-alpha gene expression. for the induction of remission and consolidation in patients with previously untreated acute promyelocytic leukaemia (apl) in combination with all-trans retinoic acid (atra) and/or chemotherapy and whose apl is characterised by the presence of the t(15:17) translocation or pml/rar-alpha gene expression.